194 related articles for article (PubMed ID: 10428922)
1. A novel injectable water-soluble amphotericin B-arabinogalactan conjugate.
Falk R; Domb AJ; Polacheck I
Antimicrob Agents Chemother; 1999 Aug; 43(8):1975-81. PubMed ID: 10428922
[TBL] [Abstract][Full Text] [Related]
2. Conjugation of amino-containing drugs to polysaccharides by tosylation: amphotericin B-arabinogalactan conjugates.
Ehrenfreund-Kleinman T; Golenser J; Domb AJ
Biomaterials; 2004 Jul; 25(15):3049-57. PubMed ID: 14967538
[TBL] [Abstract][Full Text] [Related]
3. Arabinogalactan protein from Arachis hypogaea: role as carrier in drug-formulations.
Parveen S; Gupta AD; Prasad R
Int J Pharm; 2007 Mar; 333(1-2):79-86. PubMed ID: 17084048
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and characterization of novel water soluble amphotericin B-arabinogalactan conjugates.
Ehrenfreund-Kleinman T; Azzam T; Falk R; Polacheck I; Golenser J; Domb AJ
Biomaterials; 2002 Mar; 23(5):1327-35. PubMed ID: 11804288
[TBL] [Abstract][Full Text] [Related]
5. Induction of interleukin-1beta, tumour necrosis factor-alpha and apoptosis in mouse organs by amphotericin B is neutralized by conjugation with arabinogalactan.
Falk R; Hacham M; Nyska A; Foley JF; Domb AJ; Polacheck I
J Antimicrob Chemother; 2005 May; 55(5):713-20. PubMed ID: 15814605
[TBL] [Abstract][Full Text] [Related]
6. Amphotericin B-gum arabic conjugates: synthesis, toxicity, bioavailability, and activities against Leishmania and fungi.
Nishi KK; Antony M; Mohanan PV; Anilkumar TV; Loiseau PM; Jayakrishnan A
Pharm Res; 2007 May; 24(5):971-80. PubMed ID: 17372682
[TBL] [Abstract][Full Text] [Related]
7. Activity, reduced toxicity, and scale-up synthesis of amphotericin B-conjugated polysaccharide.
Ickowicz DE; Farber S; Sionov E; Kagan S; Hoffman A; Polacheck I; Domb AJ
Biomacromolecules; 2014 Jun; 15(6):2079-89. PubMed ID: 24779556
[TBL] [Abstract][Full Text] [Related]
8. Polysorbate Surfactants as Drug Carriers: Tween 20-Amphotericin B Conjugates as Anti-Fungal and Anti-Leishmanial Agents.
Ravichandran V; Kesavan V; Cojean S; Loiseau PM; Jayakrishnan A
Curr Drug Deliv; 2018; 15(7):1028-1037. PubMed ID: 29732967
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of sodium deoxycholate sulfate as a lipid drug carrier to enhance the solubility, stability and safety of an amphotericin B inhalation formulation.
Gangadhar KN; Adhikari K; Srichana T
Int J Pharm; 2014 Aug; 471(1-2):430-8. PubMed ID: 24907597
[TBL] [Abstract][Full Text] [Related]
10. Efficacious treatment of experimental leishmaniasis with amphotericin B-arabinogalactan water-soluble derivatives.
Golenser J; Frankenburg S; Ehrenfreund T; Domb AJ
Antimicrob Agents Chemother; 1999 Sep; 43(9):2209-14. PubMed ID: 10471566
[TBL] [Abstract][Full Text] [Related]
11. In-vivo therapeutic efficacy in experimental murine mycoses of a new formulation of deoxycholate-amphotericin B obtained by mild heating.
Petit C; Chéron M; Joly V; Rodrigues JM; Bolard J; Gaboriau F
J Antimicrob Chemother; 1998 Dec; 42(6):779-85. PubMed ID: 10052902
[TBL] [Abstract][Full Text] [Related]
12. Distribution of amphotericin B-arabinogalactan conjugate in mouse tissue and its therapeutic efficacy against murine aspergillosis.
Falk R; Grunwald J; Hoffman A; Domb AJ; Polacheck I
Antimicrob Agents Chemother; 2004 Sep; 48(9):3606-9. PubMed ID: 15328139
[TBL] [Abstract][Full Text] [Related]
13. Synthetic polymannose as a drug carrier: synthesis, toxicity and anti-fungal activity of polymannose-amphotericin B conjugates.
Francis AP; Gurudevan S; Jayakrishnan A
J Biomater Sci Polym Ed; 2018 Sep; 29(13):1529-1548. PubMed ID: 29683392
[TBL] [Abstract][Full Text] [Related]
14. Toxicity mechanisms of amphotericin B and its neutralization by conjugation with arabinogalactan.
Kagan S; Ickowicz D; Shmuel M; Altschuler Y; Sionov E; Pitusi M; Weiss A; Farber S; Domb AJ; Polacheck I
Antimicrob Agents Chemother; 2012 Nov; 56(11):5603-11. PubMed ID: 22908154
[TBL] [Abstract][Full Text] [Related]
15. Novel oral amphotericin B formulation (iCo-010) remains highly effective against murine systemic candidiasis following exposure to tropical temperature.
Wasan KM; Sivak O; Bartlett K; Wasan EK; Gershkovich P
Drug Dev Ind Pharm; 2015; 41(9):1425-30. PubMed ID: 25170660
[TBL] [Abstract][Full Text] [Related]
16. Polymeric carriers for amphotericin B: in vitro activity, toxicity and therapeutic efficacy against systemic candidiasis in neutropenic mice.
Espuelas MS; Legrand P; Campanero MA; Appel M; Chéron M; Gamazo C; Barratt G; Irache JM
J Antimicrob Chemother; 2003 Sep; 52(3):419-27. PubMed ID: 12888593
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a Polyethylene Glycol-Amphotericin B Conjugate Loaded with Free AMB for Improved Antifungal Efficacy.
Tan TR; Hoi KM; Zhang P; Ng SK
PLoS One; 2016; 11(3):e0152112. PubMed ID: 27008086
[TBL] [Abstract][Full Text] [Related]
18. Water-soluble amphotericin B-polyvinylpyrrolidone complexes with maintained antifungal activity against Candida spp. and Aspergillus spp. and reduced haemolytic and cytotoxic effects.
Charvalos E; Tzatzarakis MN; Van Bambeke F; Tulkens PM; Tsatsakis AM; Tzanakakis GN; Mingeot-Leclercq MP
J Antimicrob Chemother; 2006 Feb; 57(2):236-44. PubMed ID: 16361329
[TBL] [Abstract][Full Text] [Related]
19. Antifungal activity of oral (Tragacanth/acrylic acid) Amphotericin B carrier for systemic candidiasis: in vitro and in vivo study.
Mohamed HA; Radwan RR; Raafat AI; Ali AE
Drug Deliv Transl Res; 2018 Feb; 8(1):191-203. PubMed ID: 29280061
[TBL] [Abstract][Full Text] [Related]
20. NanoDisk containing super aggregated amphotericin B: a high therapeutic index antifungal formulation with enhanced potency.
Burgess BL; He Y; Baker MM; Luo B; Carroll SF; Forte TM; Oda MN
Int J Nanomedicine; 2013; 8():4733-43. PubMed ID: 24379661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
